click below
click below
Normal Size Small Size show me how
Patho L2 CH2
Patho L2
| Question | Answer |
|---|---|
| Etiology | the cause of something The beginnings and the reasons behind it |
| Etiologic agents | Causes of the cell alteration or disease |
| ***Characteristics changes with specific etiologic agents EX: Cold temperature causes frostbite, streptococcal bacteria causes sore throat | |
| In response to an etiologic agent, cell may | Develop adaptive, compensatory changes Develop maladaptive changes |
| Histology | Microscopic study of tissue |
| Biopsy | Sample for histological analysis |
| Autopsy | Examination of tissue of deceased organisms |
| Pathognomic changes | Unique, identifying disease presentations EX: Crate-like formation in stomach indicates ulcer |
| Atrophy | Cells revert to smaller size EX: SMA |
| Hypertrophy | Increase in individual cell size EX: Strength training |
| Physiological | Cell enlargement with adequate supporting tissues EX: enlargement of cardiac cells with exercise training |
| Pathological | Increase in cell size, without increase in support structures EX: enlargement of heart tissue due to hypertension |
| Hyperplasia | Increase in number of cells Only in cells capable of mitosis Can result from hormonal stimulation EX: estrogen stimulates growth of breast cells in pregnancy |
| Hyperplasia may evolve into | maladaptive compensation Cell number increases too much EX: keloid formation |
| Metaplasia | Replacement of one cell type with another Genetic reprogramming |
| Dysplasia | Deranged cellular growth Often a result of chronic inflammation or a precancerous condition Cells vary in size, shape, and organization compared with normal EX: Cervical dysplasia detected by PAP smear |
| Neoplasia | When you make the jump from dysplasia to neoplasia New growth, disorganized, cancerous Often interchanged with the term tumor Neoplasms may be benign of malignant |
| Benign | Cells resemble normal cells. Do not metastasize. Well-defined borders |
| Malignant | Cells appear different from healthy cells. Poorly defined borders |
| Hypoxia | Diminished oxygen to cells Most common cause of cell injury Due to ischemia, problems with RBCs, pulmonary issues Causes cells to enter anaerobic metabolism, lactic acid levels increase |
| Free radical injury | Formed during aerobic metabolism AKA: REOs |
| REOs | Contain unpaired electrons which interact with and disrupt plasma membrane Series of enzymes, superoxide dismutases Oxidative stress: protective mechanisms overwhelmed |
| Physical agents | Example: lacerations, falls, temperature extremes, burns, electrical shock |
| Chemical injury Endogenous Exogenous | End: Elevated ions; high blood glucose Exo: Drugs, pollutants, smoking |
| Infectious agents | Bacteria Fungi Parasites |
| Injurious immunological reactions | Autoimmune diseases Chronic inflammation |
| Nutritional imbalances | Cells cannot function without proper amounts of macromolecules, vitamins, and minerals |
| Endothelium | Cells that line interior of vessels Common agents of injury to endothelium Active tissue Injury may lead to atherosclerosis |
| Common agents of injury to endothelium | Hypertension Hyperglycemia Free radicals Hyperlipidemia |
| Hypertension- Endothelial Injuries | Stronger than normal shearing force Aneurysm Weakened area of arterial wall, may rupture |
| Diabetic hyperglycemia- Endothelial Injuries | Glucose reacts with endothelium Advanced glycation end products form, which further damages the endothelium Endothelin, a potent vasoconstrictor, is released |
| Free Radicals- Endothelial Injuries | Highly reactive oxidizing molecules which can injure the endothelium Cigarette smoking increases free radicals |
| Persistent angiotensin II secretion- Endothelial Injuries | Potent vasoconstrictor, increases blood pressure force on endothelium Elevated with heart disease |
| Atherogenesis | Formation of atherosclerotic plaque |
| Low Density Lipoprotein Cholesterol (LDL-C)- Endothelial Injuries | Atherogenesis: Formation of atherosclerotic plaque Endothelial injury LDL-C deposition Foam cell and plaque formation |
| Cell degeneration | Apoptosis |
| Programmed cell death | Organized process that does not cause inflammation or adversely affect surrounding tissues Some diseases may be associated with apoptosis dysfunction EX: Prostate Cancer (decreased apoptosis) SMA: (increased apoptosis) |
| Necrosis | cell death due irreversible process Membrane disintegrates, lysosomal activation and autolysis Initiates inflammatory reaction |
| Interventions to prevent permanent cell injury | Transplantation of organ or healthy tissue Regenerative medicine using stem cells Human umbilical cord-mesenchymal stem cells (HUC-MSCs) Therapeutic cloning Reproductive cloning |
| Issues with transplantation of organ | Issues: Short supply of tissues/organs Donor matching Transplant rejection |
| ***Remember Hypoxia Our limit is short, >6 minutes before brain death |